Session » Abstracts: SLE – Diagnosis, Manifestations, and Outcomes II: Complications
- 3:00PM-4:30PM
-
Abstract Number: 1595
Association of Sustained Lupus Low Disease Activity State with Improved Outcomes in SLE: A Multinational Prospective Cohort Study
- 3:00PM-4:30PM
-
Abstract Number: 1593
Epidemiology and Outcomes of Infection-related Hospitalizations in Young Adults with SLE: Data from National Inpatient Sample
- 3:00PM-4:30PM
-
Abstract Number: 1594
Incidence of Pneumocystis Jirovecii Pneumonia and Prophylaxis-Associated Adverse Events Among Patients with Systemic Lupus Erythematosus
- 3:00PM-4:30PM
-
Abstract Number: 1591
Overall and Post-vaccination Prevalence of Severe COVID-19-related Events Among Commercially Insured Patients with Systemic Lupus Erythematosus and the General U.S. Population
- 3:00PM-4:30PM
-
Abstract Number: 1592
Serious Infections in SLE- Incidence, Associated Factors, Impact and Trends over Two Decades
- 3:00PM-4:30PM
-
Abstract Number: 1596
The Role of Coronary Calcium Screening in Patients with Lupus Who Appear to Be at Low Cardiovascular Risk